• Coherus Reports Positive 24-Week Trial Results for Humira Biosimilar in Psoriasis Patients
  • Possibly Pivotal Phase 3 Trial Shows Combo Lotion, IDP-118, Ably Treats Plaque Psoriasis
  • Psoriasis May Be Associated with Liver Disease, Research Shows
  • Otezla Improves Psoriatic Arthritis Symptoms, Study Shows
  • Licensing Deal Worth $790M Reached For Potential Psoriasis Treatment, AST-005
  • Scientists Identify Molecules that Link Psoriasis and Heart Disease
  • Psoriasis Foundation Issues Treatment Goals to Help Patients Judge a Therapy’s Benefit
  • Stelara May Block Protein That Fights Psoriasis, Study Says
  • Phase 2 Study of Oral Treatment for Plaque Psoriasis, LYC-30937-EC, Starts in US
  • Phase 3 Trials Show Response to Xeljanz in People with Active Psoriatic Arthritis
  • Novan’s Nitric Oxide-Releasing Therapy Candidate Shows Positive Results for Psoriasis
  • Psoriatic Arthritis Often Misunderstood and Difficult to Diagnose, Survey Finds